Ulrike Jaegle
Company: CureVacSE
Job title: Vice President - Global Regulatory Affairs & Pre-Clinical Safety
Seminars:
Panel Discussion – A European Industry & Regulatory Perspective Into the Development & Route to Approval for Personalised mRNA Cancer Therapies 5:30 pm
Uncovering how successful mRNA cancer vaccine trials are selecting patients and achieving clinical endpoints How to reduce the personalised cancer vaccine timeline by central manufacturing and optimised logistics Navigating the regulatory frameworks for personalised medicine to ensure success post-approval Navigating the regulatory frameworks for personalised medicine to ensure success post-approvalRead more
day: Day 1 PM